KBC Group
BHVN icon

KBC Group’s Biohaven BHVN Stock Holding History

KBC Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39K Hold
4,560
– – ﹤0.01% 1727
2025
Q4 		$51K Hold
4,560
– – ﹤0.01% 1631
2025
Q3 		$68K Hold
4,560
– – ﹤0.01% 1501
2025
Q2 		$64K Hold
4,560
– – ﹤0.01% 1471
2025
Q1 		$110K Buy
4,560
+1,183
+35% +$41.7K ﹤0.01% 1424
2024
Q4 		$126K Buy
3,377
+1,127
+50% +$52.6K ﹤0.01% 1395
2024
Q3 		$112K Buy
2,250
+443
+25% +$17.2K ﹤0.01% 1212
2024
Q2 		$63K Hold
1,807
– – ﹤0.01% 1472
2024
Q1 		$99K Buy
1,807
+83
+5% +$4.11K ﹤0.01% 1128
2023
Q4 		$74K Buy
1,724
+693
+67% +$21.6K ﹤0.01% 1252
2023
Q3 		$27K Buy
+1,031
New +$21.4K ﹤0.01% 1826

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KBC Group's BHVN Position: Q1 2026 in Review

KBC Group held its Biohaven (BHVN) position steady in Q1 2026 at 4,560 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

KBC Group first reported a position in BHVN in Q3 2023 and has held it in 11 quarters since. The position peaked at $126K in Q4 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • KBC Group held 4,560 shares of Biohaven worth $39K as of Q1 2026.
  • KBC Group left its Biohaven share count unchanged in Q1 2026.
  • Biohaven made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1727 holding.
  • KBC Group first reported a position in Biohaven in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Biohaven position peaked at $126K in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.